|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 45/06 | (2006.01) |
| A61K 31/13 | (2006.01) | ||
| A61K 31/27 | (2006.01) | ||
| A61K 31/445 | (2006.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 3500306 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17764658.5 |
| Date of filing the European patent application | 2017-08-14 | |
| (97) | Date of publication of the European application | 2019-06-26 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-08 |
| (46) | Date of publication of the claims translation | 2020-10-12 |
| (86) | Number | PCT/IB2017/054939 |
| Date | 2017-08-14 |
| (87) | Number | WO 2018/033848 |
| Date | 2018-02-22 |
| (30) | Number | Date | Country code |
| 201641028165 | 2016-08-18 | IN |
| (72) |
NIROGI, Ramakrishna, IN
SHINDE, Anil Karbhari, IN
MOHAMMED, Abdul Rasheed, IN
JAYARAJAN, Pradeep, IN
BHYRAPUNENI, Gopinadh, IN
JASTI, Venkateswarlu, IN
|
| (73) |
Suven Life Sciences Limited,
Serene Chambers Road No. 5 Avenue 7 Banjara Hills, Hyderabad, Telangana 500034,
IN
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Trigubas derinys iš histamino-3 receptoriaus atvirkštinių agonistų, acetilcholinesterazės inhibitorių ir NMDA receptoriaus antagonisto |
| TRIPLE COMBINATION OF HISTAMINE-3 RECEPTOR INVERSE AGONISTS, ACETYLCHOLINESTERASE INHIBITORS AND NMDA RECEPTOR ANTAGONIST |
| Payment date | Validity (years) | Amount | |
| 2022-07-18 | 6 | 139.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-08-14 |